Genetics of prostate cancer

被引:0
|
作者
Schörghofer D. [1 ]
Uyanik G. [1 ,2 ]
Rötzer K. [1 ,2 ]
机构
[1] Zentrum für Medizinische Genetik, Hanusch-Krankenhaus der Wiener Gebietskrankenkasse, Heinrich-Collin-Straße 30, Wien
[2] Medizinische Fakultät, Sigmund Freud Privatuniversität, Freudplatz 3, Wien
来源
Journal für Urologie und Urogynäkologie/Österreich | 2019年 / 26卷 / 4期
关键词
BRCA; Familial cancer syndrome; Genetic counselling; HOXB13; Personalised medicine;
D O I
10.1007/s41972-019-0077-z
中图分类号
学科分类号
摘要
Prostate cancer is the most prevalent cancer and the third most prevalent cause of death in European men. Treatment and early detection of prostate cancer have vastly improved during the last few years. However, it is crucial to identify those patients who have an increased risk for prostate cancer, since those individuals could profit from an intensified surveillance program. About 10% of all prostate cancers are presumably caused by a cancer syndrome of monogenic inheritance. The genes known to be most commonly associated with prostate cancer are BRCA1, BRCA2 and HOXB13. Additionally, a number of other genes, including genes involved in Lynch syndrome, are suspected to increase the risk for prostate cancer. In addition, mutations in certain genes like BRCA1 and BRCA2 have great impact on histopathological characteristics, prognosis and clinical course of prostate cancer. Most importantly, recent studies have suggested that BRCA-mutated prostate cancer is especially sensitive to platin-based chemotherapy, similarly as is the case with breast and ovarian cancer. Therefore, patients with BRCA mutations might profit from a therapy with PARP inhibitors. In any case, the detection of a familial mutation in a patient with prostate cancer enables predictive testing of relatives to evaluate the individual cancer risk, subsequently giving the chance to offer intensified surveillance to those at risk and to relieve those who have not inherited the mutation. © 2019, Springer-Verlag GmbH Austria, ein Teil von Springer Nature.
引用
收藏
页码:107 / 113
页数:6
相关论文
共 50 条
  • [1] Genetics Prostate cancer
    Blaine, Sean M.
    Honeywell, Christina
    Allanson, Judith
    Cremin, Carol
    Dorman, Heather
    Gibbons, Clare A.
    Meschino, Wendy S.
    Permaul, Joanne
    Carroll, June C.
    CANADIAN FAMILY PHYSICIAN, 2009, 55 (07) : 710 - U40
  • [2] Genetics of prostate cancer
    Thomas, F
    Jaïs, P
    Cohen-Akenine, A
    BULLETIN DU CANCER, 2001, 88 (03) : 287 - 294
  • [3] Molecular genetics of prostate cancer
    Royer-Pokora, B
    JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (04): : B9 - B9
  • [4] Molecular genetics of prostate cancer
    Elo, JP
    Visakorpi, T
    ANNALS OF MEDICINE, 2001, 33 (02) : 130 - 141
  • [5] Genetics of Prostate Cancer Risk
    Pomerantz, Mark M.
    Freedman, Matthew L.
    MOUNT SINAI JOURNAL OF MEDICINE, 2010, 77 (06): : 643 - 654
  • [6] Molecular genetics of prostate cancer
    Visakorpi, T.
    INTERNATIONAL JOURNAL OF ANDROLOGY, 2010, 33 : 31 - 31
  • [7] Germline genetics of prostate cancer
    Khan, Hiba M.
    Cheng, Heather H.
    PROSTATE, 2022, 82 : S3 - S12
  • [8] Molecular genetics of prostate cancer
    Isaacs, WB
    CANCER SURVEYS, 1995, 25 : 357 - 379
  • [9] Molecular genetics of prostate cancer
    Visakorpi, T
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 56 - 56
  • [10] Genetics and genomics of prostate cancer
    Dean, Michael
    Lou, Hong
    ASIAN JOURNAL OF ANDROLOGY, 2013, 15 (03) : 309 - 313